{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:12:14Z","timestamp":1789726334971,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Corynebacterium striatum<\/jats:italic>\n                      is a gram-positive facultative anaerobe found in the environment and human flora that has historically been considered a contaminant. More recently,\n                      <jats:italic>Corynebacterium striatum<\/jats:italic>\n                      has been implicated in human infections, including respiratory infections, endocarditis, and bone and joint infections, particularly those involving hardware or implanted devices.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 65-year-old man presented for washout of his left total knee arthroplasty following a revision 20\u00a0days prior. The patient underwent debridement of his left total knee and revision of the left total femur arthroplasty. Daptomycin was initiated empirically due to a previous rash from vancomycin. Operative tissue cultures grew\n                      <jats:italic>Staphylococcus haemolyticus<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                      and\n                      <jats:italic>Corynebacterium striatum<\/jats:italic>\n                      . Given concern for daptomycin resistance and the reliability of vancomycin susceptibility, daptomycin was discontinued and vancomycin initiated following a graded challenge. Within a few days, the patient developed a diffuse, blanching, erythematous, maculopapular rash and daptomycin was restarted. Over the next 72\u00a0h, his rash progressed and he met criteria for drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Daptomycin was stopped and oral linezolid initiated; rash improved.\n                      <jats:italic>C. striatum<\/jats:italic>\n                      returned with susceptibility to gentamicin, linezolid, vancomycin and daptomycin. Due to concern for adverse effects on long-term linezolid, daptomycin was restarted and was tolerated for 20\u00a0days, at which point purulent drainage from incision increased. The patient underwent another arthroplasty revision and washout. Operative cultures from this surgery were again positive for\n                      <jats:italic>C. striatum<\/jats:italic>\n                      . Repeat\n                      <jats:italic>C. striatum<\/jats:italic>\n                      susceptibilities revealed resistance to daptomycin but retained susceptibility to linezolid. Daptomycin was again changed to linezolid. He completed six weeks of linezolid followed by linezolid 600\u00a0mg daily for suppression and ultimately opted for disarticulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>C. striatum<\/jats:italic>\n                      has historically been regarded as a contaminant, particularly when grown in tissue culture in the setting of prosthetic joint infection. Based on the available literature and susceptibility patterns, the most appropriate first-line therapy is vancomycin or linezolid. Treatment with daptomycin should be avoided, even when isolates appear susceptible, due to the risk of development of high-level resistance (MIC\u2009&gt;\u2009256\u00a0\u00b5g\/mL) and clinical failure.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07270-0","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:03:13Z","timestamp":1648472593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-5937","authenticated-orcid":false,"given":"Amber C.","family":"Streifel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara D.","family":"Varley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoungYoon","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica K.","family":"Sikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"James S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"7270_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jinf.2004.05.005","volume":"50","author":"PP Lee","year":"2005","unstructured":"Lee PP, Ferguson DA, Sarubbi FA. Corynebacterium striatum: an underappreciated community and nosocomial pathogen. J Infect. 2005;50:338\u201343.","journal-title":"J Infect"},{"issue":"672","key":"7270_CR2","first-page":"1","volume":"19","author":"JN Ramos","year":"2019","unstructured":"Ramos JN, Souza C, Faria YV, da Silva EC, Veras JFC, Baio PVP, Seabra SH, Moreira LO, Junior RH, Mattos-Guaraldi AL, Viera VV. Bloodstream and catheter-related infections due to different clones of multidrug-resistant and biofilm producer Corynebacterium striatum. BMC Infect Dis. 2019;19(672):1\u201311.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"7270_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1590\/0074-02760140373","volume":"110","author":"C de Souza","year":"2015","unstructured":"de Souza C, Faria YV, SantAnna LO, Viana VG, Seabra SH, De Souza MC, Vieira VV, Junior RH, Moreira LDO, de Mattos-Guaraldi AL. Biofilm production by multiresistant Corynebacterium striatum associated with nosocomial outbreaks. Mem Inst Oswaldo Cruz. 2015;110(2):242\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7270_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ajcp\/aqv006","volume":"145","author":"N Suwantarat","year":"2016","unstructured":"Suwantarat N, Weik C, Romagnoli M, Ellis BC, Kwiatkowski N, Carroll KC. Practical utility and accuracy of matrix-assisted laser desporption ionization-time of flight mass spectrometry for identification of Corynebacterium species and other medically relevant coryneform-like bacteria. Am J Clin Pathol. 2016;145:22\u20138.","journal-title":"Am J Clin Pathol"},{"key":"7270_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s100960050336","volume":"18","author":"J Esteban","year":"1999","unstructured":"Esteban J, Nieto E, Calvo R, Fernandez-Roblas R, Valero-Guillen PL, Soriano F. Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis. 1999;18:518\u201321.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7270_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0923-2508(02)01324-4","volume":"153","author":"S Voisin","year":"2002","unstructured":"Voisin S, Deruaz D, Freney J, Renaud FNR. Differentiation of Corynebacterium amycolatum, C. minutissimum, C striatum and related species by pyrolysis-gas-liquid chromatography with atomic emission detection. Res Microbiol. 2002;153:307\u201311.","journal-title":"Res Microbiol."},{"issue":"11","key":"7270_CR7","doi-asserted-by":"publisher","first-page":"e01111","DOI":"10.1128\/AAC.01111-17","volume":"61","author":"AR McMullen","year":"2017","unstructured":"McMullen AR, Anderson N, Wallace MA, Shupe A, Burnham CD. When good bugs go bad: epidemiology and antimicrobial resistance profiles of Corynebacterium striatum, an emerging multidrug-resistant, opportunistic pathogen. Antimicrob Agents Chemother. 2017;61(11):e01111-e1117.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"7270_CR8","doi-asserted-by":"publisher","first-page":"e01200","DOI":"10.1128\/JCM.01200-18","volume":"56","author":"F Kalt","year":"2018","unstructured":"Kalt F, Schulthess B, Sidler F, Herren S, Fucentese SF, Zingg PO, Berli M, Zinkernagel AS, Zbinden R, Achermann Y. Corynebacterium species rarely cause orthopedic infections. J Clin Microbiol. 2018;56(12):e01200-e1218.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"7270_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckleberg JM, Rao N, Hanssen A, Wilson WR. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1-25.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"7270_CR10","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/infdis\/jiw480","volume":"22","author":"WO Hahn","year":"2016","unstructured":"Hahn WO, Werth BJ, Butler-Wu SM, Rakita RM. Multidrug-resistant Corynebacterium striatum associated with increased use of parenteral antimicrobial drugs. Emerg Infect Dis. 2016;22(11):1980\u20132014.","journal-title":"Emerg Infect Dis"},{"key":"7270_CR11","unstructured":"CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 3rd edn, CLSI guideline M45. Wayne, PA: Clinical and Laboratory Standards Institute; 2016"},{"issue":"4","key":"7270_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1128\/CMR.00030-13","volume":"26","author":"RM Humphries","year":"2013","unstructured":"Humphries RM, Pollett S, Sakoulas G. A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev. 2013;26(4):759\u201380.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"7270_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/jac\/dkh198","volume":"53","author":"AP Johnson","year":"2004","unstructured":"Johnson AP, Mushtaq S, Warner M, Livermore DM. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Oso-Sensitest agar. J Antimicrob Chemother. 2004;53(5):860\u20132.","journal-title":"J Antimicrob Chemother"},{"key":"7270_CR14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10096-019-03542-x","volume":"38","author":"L Noussair","year":"2019","unstructured":"Noussair L, Salomon E, El Sayed F, Duran C, Bouchand F, Roux AL, Gaillard JL, Bauer T, Rottman M, Dinh A. Monomicrobial bone and joint infection due to Corynebacterium striatum: literature review and amoxicillin-rifampin combination as treatment perspective. Eur J Clin Microbiol Infect Dis. 2019;38:1269\u201378.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7270_CR15","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202163049","volume":"63","author":"MN Milosavljevic","year":"2021","unstructured":"Milosavljevic MN, Milosavljevic JZ, Kocovic AG, et al. Antimicrobial treatment of Corynebacterium striatum invasive infections: a systematic review. Rev Inst Med Trop Sao Paulo. 2021;63: e49.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"6","key":"7270_CR16","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1128\/AAC.00046-12","volume":"56","author":"TT Tran","year":"2012","unstructured":"Tran TT, Jaijakul S, Lewis CT, Diaz L, Panesso D, Kaplan HB, Murray BE, Wagner A, Arias CA. Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy? Antimicrob Agents Chemother. 2012;56(6):3461\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"7270_CR17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s10096-014-2188-6","volume":"33","author":"EM TeKippe","year":"2014","unstructured":"TeKippe EM, Thomas BS, Ewald GA, Lawrence SJ, Burnham CD. Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum\u2026 a cautionary tale. Eur J Clin Microbiol Infect Dis. 2014;33(12):2199\u2013205.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"7270_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/mdr.2015.0208","volume":"22","author":"BJ Werth","year":"2016","unstructured":"Werth BJ, Hahn WO, Butler-Wu SM, Rakita RM. Emergence of high-level daptomycin resistance in Corynebacterium striatum in two patients with left ventricular assist device infections. Microb Drug Resist. 2016;22(3):233\u20137.","journal-title":"Microb Drug Resist"},{"key":"7270_CR19","doi-asserted-by":"crossref","unstructured":"IDSA. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical Infectious Diseases. 2011; 52(3):e18\u2013e55.","DOI":"10.1093\/cid\/ciq146"},{"issue":"7","key":"7270_CR20","doi-asserted-by":"publisher","first-page":"e00705","DOI":"10.1128\/AAC.00705-17","volume":"61","author":"S Ajmal","year":"2017","unstructured":"Ajmal S, Saleh OA, Beam E. Development of high-grade daptomycin resistance in a patient being treated for Corynebacterium striatum infection. Antimicrob Agents Chemother. 2017;61(7):e00705-e717.","journal-title":"Antimicrob Agents Chemother"},{"key":"7270_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijantimicag.2012.06.001","volume":"40","author":"ML Fernandez Guerrero","year":"2012","unstructured":"Fernandez Guerrero ML, Molins A, Rey M, Romero J, Gadea I. Multi-drug resistant Corynebacterium striatum endocarditis successfully treated with daptomycin. Int J Antimicrob Agents. 2012;40:373\u20134.","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"7270_CR22","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1345\/aph.1G242","volume":"39","author":"M Shah","year":"2005","unstructured":"Shah M, Murillo JL. Successful treatment of Corynebacterium striatum Endocarditis with Daptomycin plus Rifampin. Ann Pharmacother. 2005;39(10):1741\u20134. https:\/\/doi.org\/10.1345\/aph.1G242.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"7270_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","volume":"1277","author":"AS Bayer","year":"2013","unstructured":"Bayer AS, Schneider T, Sahl HG. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann NY Acad Sci. 2013;1277(1):139\u201358.","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"7270_CR24","doi-asserted-by":"publisher","first-page":"e00371","DOI":"10.1128\/mSphereDirect.00371-18","volume":"3","author":"NK Goldner","year":"2018","unstructured":"Goldner NK, Bulow C, Cho K, Wallace M, Hsu FF, Patti GJ, Burnham CA, Schlesinger P, Dantas G. Mechanism of high-level daptomycin resistance in Corynebacterium striatum. mSphere. 2018;3(4):e00371-e418.","journal-title":"mSphere."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07270-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:03:49Z","timestamp":1648472629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07270-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7270"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07270-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Oregon Health and Science University approved this study (STUDY00020228).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant has consented to the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}